// <auto-generated/>
// Contents of: hl7.fhir.r4.core version: 4.0.1
// Minimum TypeScript Version: 3.7
// FHIR ValueSet: http://terminology.hl7.org/ValueSet/v3-ActSubstanceAdminSubstitutionCode|2014-03-26
import { Coding } from '../fhir/Coding.js';
/**
 * No Description Provided
 */
export const V3ActSubstanceAdminSubstitutionCodeCodings = {
    /**
     * BC: Description:
     *
     *
     *                         Substitution occurred or is permitted between equivalent Brands but not Generics
     *
     *
     *                            Examples:
     *
     *
     *
     *                            Zestril  for Prinivil
     *                            Coumadin for Jantoven
     */
    BrandComposition: new Coding({
        display: "brand composition",
        code: "BC",
        system: "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
    }),
    /**
     * E: Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.
     */
    Equivalent: new Coding({
        display: "equivalent",
        code: "E",
        system: "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
    }),
    /**
     * EC: Description:
     *
     *
     *                         Substitution occurred or is permitted with another product that is a:
     *
     *
     *                            pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
     *                            pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration
     *
     *
     *                            Examples:
     *
     *
     *
     *
     *                               Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate
     *
     *                               Pharmaceutical equivalent: Lisonpril for Zestril
     */
    EquivalentComposition: new Coding({
        display: "equivalent composition",
        code: "EC",
        system: "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
    }),
    /**
     * F: Description: This substitution was performed or is permitted based on formulary guidelines.
     */
    Formulary: new Coding({
        display: "formulary",
        code: "F",
        system: "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
    }),
    /**
     * G: Description: Substitution occurred or is permitted between equivalent Generics but not Brands
     *
     *
     *                            Examples:
     *
     *
     *
     *                            Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
     */
    GenericComposition: new Coding({
        display: "generic composition",
        code: "G",
        system: "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
    }),
    /**
     * N: No substitution occurred or is permitted.
     */
    None: new Coding({
        display: "none",
        code: "N",
        system: "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
    }),
    /**
     * TB: Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics
     * &gt;
     *                            Examples:
     *
     *
     *
     *                            Zantac for Tagamet
     */
    TherapeuticBrand: new Coding({
        display: "therapeutic brand",
        code: "TB",
        system: "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
    }),
    /**
     * TE: Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.
     *
     *
     *                            Examples:
     *
     *
     *
     *                            ranitidine for Tagamet
     */
    TherapeuticAlternative: new Coding({
        display: "therapeutic alternative",
        code: "TE",
        system: "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
    }),
    /**
     * TG: Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands
     * &gt;
     *                            Examples:
     *
     *
     *
     *                            Ranitidine  for cimetidine
     */
    TherapeuticGeneric: new Coding({
        display: "therapeutic generic",
        code: "TG",
        system: "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
    }),
};
//# sourceMappingURL=data:application/json;base64,{"version":3,"file":"V3ActSubstanceAdminSubstitutionCodeCodings.js","sourceRoot":"./src/","sources":["fhirValueSets/V3ActSubstanceAdminSubstitutionCodeCodings.ts"],"names":[],"mappings":"AAAA,oBAAoB;AACpB,+CAA+C;AAC/C,kCAAkC;AAClC,qGAAqG;AAErG,OAAO,EAAE,MAAM,EAAE,MAAM,mBAAmB,CAAA;AAE1C;;GAEG;AACH,MAAM,CAAC,MAAM,0CAA0C,GAAG;IACxD;;;;;;;;;;;;;OAaG;IACH,gBAAgB,EAAE,IAAI,MAAM,CAAC;QAC3B,OAAO,EAAE,mBAAmB;QAC5B,IAAI,EAAE,IAAI;QACV,MAAM,EAAE,qEAAqE;KAC9E,CAAC;IACF;;OAEG;IACH,UAAU,EAAE,IAAI,MAAM,CAAC;QACrB,OAAO,EAAE,YAAY;QACrB,IAAI,EAAE,GAAG;QACT,MAAM,EAAE,qEAAqE;KAC9E,CAAC;IACF;;;;;;;;;;;;;;;;;;;OAmBG;IACH,qBAAqB,EAAE,IAAI,MAAM,CAAC;QAChC,OAAO,EAAE,wBAAwB;QACjC,IAAI,EAAE,IAAI;QACV,MAAM,EAAE,qEAAqE;KAC9E,CAAC;IACF;;OAEG;IACH,SAAS,EAAE,IAAI,MAAM,CAAC;QACpB,OAAO,EAAE,WAAW;QACpB,IAAI,EAAE,GAAG;QACT,MAAM,EAAE,qEAAqE;KAC9E,CAAC;IACF;;;;;;;;;OASG;IACH,kBAAkB,EAAE,IAAI,MAAM,CAAC;QAC7B,OAAO,EAAE,qBAAqB;QAC9B,IAAI,EAAE,GAAG;QACT,MAAM,EAAE,qEAAqE;KAC9E,CAAC;IACF;;OAEG;IACH,IAAI,EAAE,IAAI,MAAM,CAAC;QACf,OAAO,EAAE,MAAM;QACf,IAAI,EAAE,GAAG;QACT,MAAM,EAAE,qEAAqE;KAC9E,CAAC;IACF;;;;;;;;OAQG;IACH,gBAAgB,EAAE,IAAI,MAAM,CAAC;QAC3B,OAAO,EAAE,mBAAmB;QAC5B,IAAI,EAAE,IAAI;QACV,MAAM,EAAE,qEAAqE;KAC9E,CAAC;IACF;;;;;;;;;OASG;IACH,sBAAsB,EAAE,IAAI,MAAM,CAAC;QACjC,OAAO,EAAE,yBAAyB;QAClC,IAAI,EAAE,IAAI;QACV,MAAM,EAAE,qEAAqE;KAC9E,CAAC;IACF;;;;;;;;OAQG;IACH,kBAAkB,EAAE,IAAI,MAAM,CAAC;QAC7B,OAAO,EAAE,qBAAqB;QAC9B,IAAI,EAAE,IAAI;QACV,MAAM,EAAE,qEAAqE;KAC9E,CAAC;CACM,CAAC","sourcesContent":["// <auto-generated/>\r\n// Contents of: hl7.fhir.r4.core version: 4.0.1\r\n// Minimum TypeScript Version: 3.7\r\n// FHIR ValueSet: http://terminology.hl7.org/ValueSet/v3-ActSubstanceAdminSubstitutionCode|2014-03-26\r\n\r\nimport { Coding } from '../fhir/Coding.js'\r\n\r\n/**\r\n * No Description Provided\r\n */\r\nexport const V3ActSubstanceAdminSubstitutionCodeCodings = {\r\n  /**\r\n   * BC: Description: \r\n   *                         \r\n   * \r\n   *                         Substitution occurred or is permitted between equivalent Brands but not Generics\r\n   * \r\n   *                         \r\n   *                            Examples: \r\n   *                         \r\n   * \r\n   *                         \r\n   *                            Zestril  for Prinivil\r\n   *                            Coumadin for Jantoven\r\n   */\r\n  BrandComposition: new Coding({\r\n    display: \"brand composition\",\r\n    code: \"BC\",\r\n    system: \"http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution\",\r\n  }),\r\n  /**\r\n   * E: Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.\r\n   */\r\n  Equivalent: new Coding({\r\n    display: \"equivalent\",\r\n    code: \"E\",\r\n    system: \"http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution\",\r\n  }),\r\n  /**\r\n   * EC: Description: \r\n   *                         \r\n   * \r\n   *                         Substitution occurred or is permitted with another product that is a:\r\n   * \r\n   *                         \r\n   *                            pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester\r\n   *                            pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration\r\n   *                         \r\n   *                         \r\n   *                            Examples: \r\n   *                         \r\n   * \r\n   *                         \r\n   *                            \r\n   *                               Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate\r\n   *                            \r\n   *                               Pharmaceutical equivalent: Lisonpril for Zestril\r\n   */\r\n  EquivalentComposition: new Coding({\r\n    display: \"equivalent composition\",\r\n    code: \"EC\",\r\n    system: \"http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution\",\r\n  }),\r\n  /**\r\n   * F: Description: This substitution was performed or is permitted based on formulary guidelines.\r\n   */\r\n  Formulary: new Coding({\r\n    display: \"formulary\",\r\n    code: \"F\",\r\n    system: \"http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution\",\r\n  }),\r\n  /**\r\n   * G: Description: Substitution occurred or is permitted between equivalent Generics but not Brands\r\n   * \r\n   *                         \r\n   *                            Examples: \r\n   *                         \r\n   * \r\n   *                         \r\n   *                            Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)\r\n   */\r\n  GenericComposition: new Coding({\r\n    display: \"generic composition\",\r\n    code: \"G\",\r\n    system: \"http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution\",\r\n  }),\r\n  /**\r\n   * N: No substitution occurred or is permitted.\r\n   */\r\n  None: new Coding({\r\n    display: \"none\",\r\n    code: \"N\",\r\n    system: \"http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution\",\r\n  }),\r\n  /**\r\n   * TB: Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics\r\n   * &gt;\r\n   *                            Examples: \r\n   *                         \r\n   * \r\n   *                         \r\n   *                            Zantac for Tagamet\r\n   */\r\n  TherapeuticBrand: new Coding({\r\n    display: \"therapeutic brand\",\r\n    code: \"TB\",\r\n    system: \"http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution\",\r\n  }),\r\n  /**\r\n   * TE: Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.\r\n   * \r\n   *                         \r\n   *                            Examples: \r\n   *                         \r\n   * \r\n   *                         \r\n   *                            ranitidine for Tagamet\r\n   */\r\n  TherapeuticAlternative: new Coding({\r\n    display: \"therapeutic alternative\",\r\n    code: \"TE\",\r\n    system: \"http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution\",\r\n  }),\r\n  /**\r\n   * TG: Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands\r\n   * &gt;\r\n   *                            Examples: \r\n   *                         \r\n   * \r\n   *                         \r\n   *                            Ranitidine  for cimetidine\r\n   */\r\n  TherapeuticGeneric: new Coding({\r\n    display: \"therapeutic generic\",\r\n    code: \"TG\",\r\n    system: \"http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution\",\r\n  }),\r\n} as const;\r\n\r\n/**\r\n * No Description Provided\r\n */\r\nexport type V3ActSubstanceAdminSubstitutionCodeCodingType = typeof V3ActSubstanceAdminSubstitutionCodeCodings;\r\n"]}